For the fifteenth year, MedAdNews has chosen new Pharmaceutical Marketing Ventures to Watch that could change the way pharmaceutical products are marketed...
Over the past few years, many clinical study administrators wanted to use the bring your own device (BYOD) The post Bringing the Benefits of eCOA BYOD...
A review of the latest executive moves in the pharma industry over the past several months.
FDA Says Ivermectin Doesn't Work Against COVID-19 But Points To Studies That Show It Does Authored by Zachary Stieber via The Epoch Times...
The FDA has started its review of Pfizer’s respiratory syncytial virus (RSV) vaccine for older adults, fast-tracking the The post RSV vaccine race in...
Clinical trials are the engine for pharmaceutical innovation, but their means of capturing and communicating data are stuck The post How a new investment...
Pfizer and BioNTech have announced that they have submitted an Emergency Use Authorisation (EUA) to the US Food The post Pfizer, BioNTech submit to FDA...
Sorrento Therapeutics’ yearslong battle with NantCell and NANTibody has come to an arbitration award, but additional legal proceedings centered around...
Nonprofit Blood Donation Service Starts Matching Unvaccinated Patients With Donors Authored by Allan Stein via The Epoch Times (emphasis ours), Swiss...
By Benjamin Boettner / Wyss Institute Communications Credit: E. Super / Wyss Institute at Harvard University By Benjamin Boettner / Wyss Institute Communications...
It is no secret that drug shortages have been prevalent in 2022. Several major drug products, such as amoxicillin and Adderall, have been in short supply...
Wednesday afternoon, Gene editing company Intellia and eye disease company Iveric Bio announced that they had each raised $300 million by selling off some...
Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in The post Steps to building...
With the Biotechnology space rotating toward a more acquisition friendly dynamic, investors may benefit from a studied focus on likely takeout candidates...
The Vaccinated Now Account For A Majority Of COVID Deaths Authored by Techno Fog via The Reactionary (emphasis ours), There’s a remarkable...
Following an invite to fly into Parma, Italy to witness first-hand the press launch of the considerable structure The post Touring Chiesi’s vision for...
Patients with fibromyalgia – a common condition causing chronic pain, fatigue, poor sleep, and cognitive dysfunction – could The post Swing’s digital...
The Truth About Ivermectin Authored by Marina Zheng via The Epoch Times (emphasis ours), Ivermectin has been hailed as a “wonder drug”...
"Grade-A Gaslighting": FDA Says Anti-Ivermectin Campaign Was 'Just A Recommendation' The US Food and Drug Administration (FDA), which mocked...
Abortion opponents sued FDA in Texas federal court Friday in a bid to have the agency reverse its long-standing decades-old approval of mifepristone, the...
Daiichi Sankyo shut down its South San Francisco subsidiary Plexxikon earlier this year. Now a new startup is looking to forge its own path — with...
SiSaf’s novel Bio-Courier delivery system that combines inorganic silicon and organic lipid vesicles offers a solution for the current shortcomings of...
CytoDyn Inc (OTCMKTS: CYDY) has formed a solid base over $0.30 and is beginning to move northbound again. The stock recently made a solid bounce from...
SafeSource Direct, LLC, the maker of high-quality, American-made personal protective equipment (PPE), announced today that its chemo-rated nitrile exam...
Futures Sink To Session Lows As Sentiment Sours US equity futures dropped to session lows, and surrendered earlier gains of as much as 0.2%,...
GOP One Seat Away From House Control: Bidens, Fauci, FDA Brace For Investigations While Democrats are assured of extending their control of...
Organicell Regenerative Medicine Inc (OTCMKTS: OCEL) is making an explosive move up the charts after the Company announced the Mayo Clinic will be the...
Nascent Biotech Inc. (OTCMKTS:NBIO) is an emerging player in the $4 billion oncology drug development space. NBIO is early-stage – its flagship drug...
The Real Story Behind RSV & The So-Called "Tripledemic" Authored by Kit Knightly via Off-Guardian.org, MSM sources are now warning of...
Cordio Medical, a medtech company based in Israel, has developed HearO, an app that can assist in monitoring congestive heart failure. The technology is...